Study of CX1106 in Patients With Advanced Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma Intervention: Drug: CX1106 Sponsors: Beijing Konruns Pharmaceutical Co., Ltd.; National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Academies | Cancer | Cancer & Oncology | Carcinoma | China Health | Head and Neck Cancer | HNSCC | Hospitals | Research | Skin Cancer | Squamous Cell Carcinoma | Study